Diffuse glomerulonephritis associated with rifampicin treatment for tuberculosis [4]

Pathology

Volumn 34, Issue 3, 2002, Pages 295-297

  Yong, Jim L C ^a   Killingsworth, Murray C ^a  

^a SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; BIOLOGICAL MARKER; TUBERCULOSTATIC AGENT;

ADULT; CASE REPORT; CELL INFILTRATION; CELL PROLIFERATION; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DISEASE COURSE; FEMALE; GLOMERULONEPHRITIS; HUMAN; KIDNEY BIOPSY; KIDNEY FUNCTION; LETTER; MESANGIUM CELL; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ENZYME IMMUNOASSAY; GLOMERULUS; LUNG TUBERCULOSIS; METABOLISM; PATHOLOGY; T LYMPHOCYTE; ULTRASTRUCTURE;

ADULT; ANTIBIOTICS, ANTITUBERCULAR; BIOLOGICAL MARKERS; FEMALE; GLOMERULONEPHRITIS; HUMANS; IMMUNOENZYME TECHNIQUES; KIDNEY GLOMERULUS; RIFAMPIN; T-LYMPHOCYTES; TUBERCULOSIS, PULMONARY;

EID: 0035985978     PISSN: 00313025     EISSN: None     Source Type: Journal    
DOI: 10.1080/00313020212468     Document Type: Article

References (10)

1. Acute renal failure during intermittent rifampicin therapy
2. Acute renal failure associated with rifampicin
3. Rifampicin-induced immune thrombocytopenia
4. Tubulointerstitial and glomerular nephritis associated with rifampicin - Report of a case
5. Crescentic fibrillary glomerulonephritis associated with intermittent rifampin therapy for pulmonary tuberculosis
6. IgA nephropathy associated with disseminated tuberculosis
7. Dense deposit disease in tuberculosis
8. Cell populations and membrane attack complex in glomeruli of patients with post-streptococcal glomerulonephritis: Identification using monoclonal antibodies by indirect immuno-fluorescence
9. The detection of monocytes in human glomerulonephritis
10. Potentially serious side effects of high-dose twice weekly rifampicin